The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000566336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
10/04/2026
Date registered
Help: Date registered
4/05/2026
Date last updated
Help: Date last updated
4/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
4/05/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
The PLEUral Effusion Rapid Analysis using DIPsticks (PLEURADIP) Study: Evaluation of Automatic Urine Dipstick Analysis as a Point of Care Test
Scientific title
The PLEUral Effusion Rapid Analysis using DIPsticks (PLEURADIP) Study: Evaluation of Automatic Urine Dipstick Analysis as a Point of Care Test in patients with pleural effusions
Additional trial identifiers [1] 316459 0
None
Universal Trial Number (UTN)
Trial acronym
PLEURADIP
Related trial records

Health condition
Health condition(s) studied:
Pleural Effusion 340574 0
Condition category
Condition code
Respiratory 336772 336772 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Hospitalised patients undergoing plueral procedures will be included in the study. Pleural fluid will be collected in a sterile specimen jar as per standard clinical practure during the pleural procedure. For patients enrolled in the study, an additional 30mls of pleural fluid will be collected in a sterile specimen jar. If there is an insufficient amount of pleural fluid available for analysis of routine pleural fluid tests, a sample for urine dipstick analysis will not be collected and the patient will not be included in the study. After the pleural procedure has been completed, the pleural fluid study sample will be dipped by a staff member with experience using urine dipsticks, with a Multistix® 10 SG Reagent Strip (Siemens) and the visual results recorded against the standardised interpretation chart as per the manufacturers instructions. A second urine dipstick will be analysed using a urine dipstick auto analyser (CLINITEK Status®+ Analyzer Siemens). Both dipsticks will be systematically analysed within 2 minutes of pleural fluid collection and results documented. Treating teams will not be informed of the dipstick results. The patients will be managed by their treating team as usual pre and post procedure, and there will be no direct impact upon patient’s care that deviates from usual standard of care practices for pleural effusion management. A review of the electronic medical record will be performed to collect formal pleural fluid laboratory results and final pleural effusion diagnosis as determined by the treating clinicians.
Intervention code [1] 333125 0
Diagnosis / Prognosis
Description of the comparator or control
Standard of care pleural fluid investigations for hospitalised patients with pleural effusions will be deterimined by the treating clinicians, Routine tests include pleural fluid and serum biochemistry to determine Light's criteria, microbiology, and cytology as clinically indicated. Laboratory samples will be analysed as per standard laboratory operating procedures.
Control group
Active

Outcomes
Primary outcome [1] 344301 0
The primary endpoint is the utility of visual and automatic pleural fluid dipstick analysis as a point of care test to diagnose: 1) Transudative effusions
Timepoint [1] 344301 0
Analysis will be performed when the formal laboratory pleural fluid results are available.
Primary outcome [2] 345156 0
The utility of visual and automatic pleural fluid dipstick analysis as a point of care test to diagnose: 2) Exudative effusions including subtypes such as pleural infections (tuberculous and non-tuberculous) and malignant effusions
Timepoint [2] 345156 0
Analysis will be performed when the formal laboratory pleural fluid results are available.
Secondary outcome [1] 457414 0
Inter-rater variability in the visual interpretation of pleural fluid dipstick results by medical staff.
Timepoint [1] 457414 0
Baseline and 24-48 hours after the first questionnaire attempt.
Secondary outcome [2] 460706 0
Intra-rater variability in the visual interpretation of pleural fluid dipstick results by medical staff.
Timepoint [2] 460706 0
Baseline and 24-48 hours after the first questionnaire attempt.

Eligibility
Key inclusion criteria
Pleural dipstick analysis
1. Patient > 18 years.
2. Informed consent for pleural procedure
3. Pleural effusion confirmed radiologically (either diagnostic ultrasound or on chest imaging) deemed safe for interventional pleural procedure and planned for pleural procedure.
4. Pleural procedure being performed.

Pleural dipstick questionnaire
1. Clinical staff with experience in urine dipstick analysis and pleural effusion management
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Pleural effusion too small for safe pleural procedure (up to the discretion of the proceduralist as per usual clinical management protocols).
2. Contraindications to pleural procedure (e.g. uncorrected coagulopathies).
3. Inability to provide informed consent for the pleural procedure.
4. Insufficient pleural fluid for dipstick analysis (<30ml).

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 29102 0
Westmead Hospital - Westmead
Recruitment postcode(s) [1] 45406 0
2145 - Westmead

Funding & Sponsors
Funding source category [1] 321070 0
Hospital
Name [1] 321070 0
Westmead Hospital
Country [1] 321070 0
Australia
Primary sponsor type
Government body
Name
Western Sydney Local Health District
Address
Country
Australia
Secondary sponsor category [1] 323778 0
None
Name [1] 323778 0
Address [1] 323778 0
Country [1] 323778 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319606 0
Western Sydney Local Health District Human Research Ethics Committee
Ethics committee address [1] 319606 0
Ethics committee country [1] 319606 0
Australia
Date submitted for ethics approval [1] 319606 0
19/09/2025
Approval date [1] 319606 0
25/09/2025
Ethics approval number [1] 319606 0
2025/ETH01416

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 147842 0
Dr Bapti Roy
Address 147842 0
Department of Respiratory and Sleep Medicine, Westmead Hospital, Cnr Darcy and Hawkesbury Rds, Westmead NSW 2145 Australia
Country 147842 0
Australia
Phone 147842 0
+61 2 8890 5635
Fax 147842 0
Email 147842 0
Contact person for public queries
Name 147843 0
Tracey Burns
Address 147843 0
Department of Respiratory and Sleep Medicine, Westmead Hospital, Cnr Darcy and Hawkesbury Rds, Westmead NSW 2145 Australia
Country 147843 0
Australia
Phone 147843 0
+61 2 8890 7785
Fax 147843 0
Email 147843 0
Contact person for scientific queries
Name 147844 0
Bapti Roy
Address 147844 0
Department of Respiratory and Sleep Medicine, Westmead Hospital, Cnr Darcy and Hawkesbury Rds, Westmead NSW 2145 Australia
Country 147844 0
Australia
Phone 147844 0
+61 2 8890 5635
Fax 147844 0
Email 147844 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.